These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36843225)

  • 1. Household transmission of SARS-CoV-2 during the Omicron wave in Shanghai, China: A case-ascertained study.
    Wei Z; Ma W; Wang Z; Li J; Fu X; Chang H; Qiu Y; Tian H; Zhu Y; Xia A; Wu Q; Liu G; Zhai X; Zhang X; Wang Y; Zeng M
    Influenza Other Respir Viruses; 2023 Feb; 17(2):e13097. PubMed ID: 36843225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmission characteristics and inactivated vaccine effectiveness against transmission of the SARS-CoV-2 Omicron BA.2 variant in Shenzhen, China.
    He X; Liao Y; Liang Y; Yu J; Gao W; Wan J; Liao Y; Su J; Zou X; Tang S
    Front Immunol; 2023; 14():1290279. PubMed ID: 38259438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission Characteristics and Inactivated Vaccine Effectiveness Against Transmission of SARS-CoV-2 Omicron BA.5 Variants in Urumqi, China.
    Wang K; Guo Z; Zeng T; Sun S; Lu Y; Wang J; Li S; Luan Z; Li H; Zhang J; Wang Y; Lu Y; Zhao S
    JAMA Netw Open; 2023 Mar; 6(3):e235755. PubMed ID: 36995713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of the booster dose of inactivated COVID-19 vaccine against Omicron BA.5 infection: a matched cohort study of adult close contacts.
    Zeng T; Lu Y; Zhao Y; Guo Z; Sun S; Teng Z; Tian M; Wang J; Li S; Fan X; Wang W; Cai Y; Liao G; Liang X; He D; Wang K; Zhao S
    Respir Res; 2023 Oct; 24(1):246. PubMed ID: 37828565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.
    Li F; Li YY; Liu MJ; Fang LQ; Dean NE; Wong GWK; Yang XB; Longini I; Halloran ME; Wang HJ; Liu PL; Pang YH; Yan YQ; Liu S; Xia W; Lu XX; Liu Q; Yang Y; Xu SQ
    Lancet Infect Dis; 2021 May; 21(5):617-628. PubMed ID: 33476567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiological and clinical features of SARS-CoV-2 infection in children during the outbreak of Omicron variant in Shanghai, March 7-31, 2022.
    Wang X; Chang H; Tian H; Zhu Y; Li J; Wei Z; Wang Y; Xia A; Ge Y; Liu G; Cai J; Zhu Q; Zhai X; Zeng M
    Influenza Other Respir Viruses; 2022 Nov; 16(6):1059-1065. PubMed ID: 36043446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.
    He X; Zeng B; Wang Y; Pang Y; Zhang M; Hu T; Liang Y; Kang M; Tang S
    Front Immunol; 2023; 14():1257360. PubMed ID: 37915583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness of booster vaccination of inactivated COVID-19 vaccines against susceptibility, infectiousness, and transmission of omicron BA.2 variant: a retrospective cohort study in Shenzhen, China.
    Liao Y; Su J; Zhao J; Qin Z; Zhang Z; Gao W; Wan J; Liao Y; Zou X; He X
    Front Immunol; 2024; 15():1359380. PubMed ID: 38881892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of COVID-19 vaccination on household transmission of SARS-CoV-2 in the Omicron era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study.
    Maeda M; Murata F; Fukuda H
    Int J Infect Dis; 2023 Sep; 134():200-206. PubMed ID: 37356650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission risks of Omicron BA.5 following inactivated COVID-19 vaccines among children and adolescents in China.
    Guo Z; Zeng T; Lu Y; Sun S; Liang X; Ran J; Wu Y; Chong MKC; Wang K; Zhao S
    Commun Med (Lond); 2024 May; 4(1):92. PubMed ID: 38762678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics and transmission dynamics of the outbreak caused by the SARS-CoV-2 Omicron variant in Shanghai, China: a descriptive study.
    Chen Z; Deng X; Fang L; Sun K; Wu Y; Che T; Zou J; Cai J; Liu H; Wang Y; Wang T; Tian Y; Zheng N; Yan X; Sun R; Xu X; Zhou X; Ge S; Liang Y; Yi L; Yang J; Zhang J; Ajelli M; Yu H
    medRxiv; 2022 Jun; ():. PubMed ID: 35765564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics of SARS-CoV-2 Omicron infection in children imported from Hong Kong].
    Ma WJ; Wang XS; Tian H; Zhu YF; Wei ZQ; Xu J; Zhu QR; Zeng M
    Zhonghua Er Ke Za Zhi; 2022 Jun; 60(6):539-544. PubMed ID: 35658359
    [No Abstract]   [Full Text] [Related]  

  • 13. Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.
    Tsang NNY; So HC; Cowling BJ; Leung GM; Ip DKM
    Lancet Infect Dis; 2023 Apr; 23(4):421-434. PubMed ID: 36521506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivated SARS-CoV-2 Vaccine Booster Against Omicron Infection Among Quarantined Close Contacts.
    Liu D; Feng S; Sha F; Liao Y; Xie X; Huang F; Kong D; Zhang Z; Chen Z; Chen N; Gao W; Feng T; Zhao Z; Li B; Li Y; Zhu F; Yang Z; Lv Q; Feng Z; Tang J
    JAMA Netw Open; 2023 Oct; 6(10):e2339507. PubMed ID: 37878315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022.
    Althaus T; Overton CE; Devaux I; House T; Lapouze A; Troel A; Vanzo B; Laroche M; Bordero A; Jorgensen P; Pebody R; Voiglio EJ
    BMC Med; 2024 Jun; 22(1):227. PubMed ID: 38840159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2.2 in China: A case-control study.
    Zhang X; Wang Y; Hu C; Xu P; Ma L; Liu L; Sun J; Liu Y; Yang H; Pan F; Hu J; Cao C; Cheng K; Gao D; Lyu Y; Qin W
    Hum Vaccin Immunother; 2023 Dec; 19(1):2194189. PubMed ID: 36998173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of BNT162b2 and Sinovac vaccines against the transmission of SARS-CoV-2 during Omicron-predominance in Hong Kong: A retrospective cohort study of COVID-19 cases.
    Zhao S; Guo Z; Sun S; Hung CT; Leung EYM; Wei Y; Wang H; Li K; Yam CHK; Chow TY; Gao J; Jia KM; Chong KC; Yeoh EK
    J Clin Virol; 2023 Sep; 166():105547. PubMed ID: 37453162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection risk among vaccinated and unvaccinated household members during the Alpha variant surge - Denver, Colorado, and San Diego, California, January-April 2021.
    McCormick DW; Konkle SL; Magleby R; Chakrabarti AK; Cherney B; Lindell K; Namageyo-Funa A; Visser S; Soto RA; Donnelly MAP; Stringer G; Austin B; Beatty ME; Stous S; Albanese BA; Chu VT; Chuey M; Dietrich EA; Drobeniuc J; Folster JM; Killerby ME; Lehman JA; McDonald EC; Ruffin J; Schwartz NG; Sheldon SW; Sleweon S; Thornburg NJ; Hughes LJ; Petway M; Tong S; Whaley MJ; Kirking HL; Tate JE; Hsu CH; Matanock A;
    Vaccine; 2022 Aug; 40(33):4845-4855. PubMed ID: 35803846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
    Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
    JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.
    Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y
    Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.